Product name:Bosutinib
CAS:380843-75-4
Molecular Formula:C26H29Cl2N5O3
Formula Weight:530.45g/mol
Description:Bosutinib is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.It can overcome not only Bcr-Abl-dependent mechanisms of resistance, but also those that are Bcr-Abl-independent.